宫颈玻璃细胞癌:国家癌症数据库联合分析及单机构治疗模式与结局回顾
研究描述宫颈玻璃细胞癌(GCCC)的分期、治疗模式与生存,比较2004-2017年NCDB中GCCC与其他组织学类型,并回顾本机构2012-2020年14例GCCC。NCDB中GCCC占143/89,001(0.16%),诊断年龄更早,早期和局部晚期总生存更差。本机构14例中早期9例均行根治性子宫切除术,3年无进展生存100%,晚期5例均为IIIC期接受根治性放化疗,3年总生存60%。
要点
- NCDB中GCCC仅占宫颈癌0.16%(143/89,001),74.8%在50岁前诊断。
- NCDB显示GCCC早期和局部晚期总生存更差,IVB期无生存差异。
- 本机构14例GCCC中早期9例均手术,3年无进展生存100%,晚期5例3年总生存60%。
核心结论
- GCCC诊断年龄早于其他宫颈癌组织学类型;NCDB显示总生存更差,但本机构较 contemporary 的回顾采用更新分期和较新治疗模式,结局与常见组织学类型历史参考更相似。
研究设计与样本
- 基于国家癌症数据库(NCDB)2004至2017年数据比较GCCC与其他组织学类型的临床数据和生存,同时回顾本机构2012至2020年GCCC病例并按2018 FIGO分期更新分期。
主要发现
- NCDB中143/89,001(0.16%)宫颈癌为GCCC,GCCC病例更年轻,74.8%在50岁前诊断。
- NCDB中GCCC分期分布与其他组织学类型相似;I期病例较少仅手术治疗(19/69,27%)。
- NCDB中79.4%的局部晚期(II-IVA期)病例接受根治性放化疗。
- NCDB中GCCC早期和局部晚期疾病总生存更差,IVB期患者未见生存差异。
- 本机构14例GCCC诊断中位年龄34岁;早期9例均行根治性子宫切除术,符合Sedlis标准者4/9(44%)接受辅助放疗;晚期5例均为IIIC期并接受根治性放化疗;早期复发率0%(0/9),晚期60%(3/5);早期3年无进展生存100%、总生存100%,晚期3年无进展生存40%、总生存60%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe stage, treatment patterns, and survival for glassy cell carcinoma of the cervix (GCCC), a poorly understood rare tumor. METHODS: Clinical data and survival were compared between GCCC and more common histologic types using the National Cancer Database (NCDB) from 2004 to 2017. A retrospective review of GCCC cases at our institution from 2012 to 2020 was simultaneously performed with staging updated according to 2018 FIGO staging. Descriptive statistics and survival analyses were performed, and outcomes compared to historical references. RESULTS: 143/89,001 (0.16%) NCDB cervical cancer cases were GCCC. Compared to other histologies, GCCC cases were younger, with 74.8% diagnosed before age 50. Stage distribution was similar. Stage I cases were less commonly treated with surgery alone (19/69, 27%). 79.4% of locally advanced (stage II-IVA) cases were treated with definitive chemoradiation. GCCC demonstrated worse OS for early-stage and locally-advanced disease. No survival differences were observed for patients with stage IVB disease. Our institutional review identified 14 GCCC cases. Median age at diagnosis was 34 years. All nine early-stage cases underwent radical hysterectomy. Adjuvant radiation was given for cases meeting Sedlis criteria (4/9, 44%). All five advanced stage cases were stage IIIC and received definitive chemoradiation. Recurrence rate was 0% (0/9) for early-stage and 60% (3/5) for advanced-stage cases. 3-year PFS was 100% for early-stage and 40% for advanced-stage. 3-year OS was 100% for early-stage and 60% for advanced-stage GCCC. CONCLUSIONS: GCCC presents at earlier ages than other cervical cancer histologic types. Although NCDB showed worse OS, our more contemporary institutional review, which incorporates updated staging and newer treatment modalities found outcomes more similar to historical references of more common histologic subtypes.
引用
- Levine MD, Barrington DA, Meade CE, et al. Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes. Gynecol Oncol. 2023. PMID: 37037083. doi:10.1016/j.ygyno.2023.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。